PURPOSE. Antimicrobial peptides (AMPs) are cationic host defense peptides with microbicidal and cell-signaling properties. They show promise as potential therapeutic agents. In the present study, a ␤-defensin AMP gene was isolated from the ocular surface for the first time, and its expression was characterized in the presence of ocular inflammation and/or infection. METHODS. Total RNA was obtained from impression cytology samples of the conjunctiva and cornea of normal patients and of those with bacterial, viral, acanthamoeba, or dry eye disease. The expression of the ␤-defensin AMP DEFB-109 was determined by using reverse transcription-polymerase chain reaction (RT-PCR). Relative quantification of the gene in the various groups was performed by means of real-time PCR. RESULTS. DEFB-109 was constitutively expressed in all samples. The gene showed significantly decreased expression in the presence of all types of inflammation/infection. Reduced expression featured most prominently in acanthamoeba infection; the least change from normal was in dry eye. CONCLUSIONS. The discovery of DEFB-109 on the ocular surface enhances our knowledge of the profile of AMPs at this important mucosal surface. The fact that its expression is significantly reduced in both inflammatory and infective ocular surface disease reflects not only an intimate balance between this host defense gene and microbes but indicates a role other than purely microbicidal. This discovery will enable the mechanisms behind the intriguing phenomenon of reduced gene expression of an AMP in disease states to be uncovered. (Invest Ophthalmol Vis Sci. 2008;49:28 -33) DOI:10.1167/iovs.07-0645 T he importance of vision in the survival of a species and the exposed location of the eyes is the likely reason for a very full repertoire of antimicrobial activities at the ocular surface. Antimicrobial peptides (AMPs) feature prominently among these. AMPs are small cationic polypeptides found in plants, invertebrates, and vertebrates. They exhibit microbicidal properties against bacteria, 1,2 fungi, mycobacteria, 3 yeasts, 4 and enveloped viruses.
T he importance of vision in the survival of a species and the exposed location of the eyes is the likely reason for a very full repertoire of antimicrobial activities at the ocular surface. Antimicrobial peptides (AMPs) feature prominently among these. AMPs are small cationic polypeptides found in plants, invertebrates, and vertebrates. They exhibit microbicidal properties against bacteria, 1,2 fungi, mycobacteria, 3 yeasts, 4 and enveloped viruses. 2 AMPs are effectors of innate immunity 5 found in mammalian neutrophils and various epithelia. They also bridge innate and adaptive immunity by participating in cell signaling 6 and acting as chemoattractants for immature dendritic and T cells. 7 They have a multitude of functions on the ocular surface, as elsewhere. Wound healing and protection from infection appear to be important functions of some AMPs, such as LL-37, and the eye is a particular case in point. 8 The AMPs even have retinal trophic and antiangiogenic properties potentially making them attractive agents for treatment of macular degeneration. 9 Increased AMP production in human tears has been found to be protective after ocular surface surgery, 10 and within the eye AMPs suppress endotoxin-induced uveitis. 11 Sometimes their presence is undesirable as when upregulation of HBD2 is associated with the ocular irritation of non-Sjögren's dry eye. 12 They belong to one of three groups, ␣-, ␤-, and -defensins, but only the first two have been isolated in humans. 13 Human ␤-defensin 1 (HBD1) is known to be constitutively expressed, 14, 15 whereas HBD2 is inducible by inflammation. 16 Both these and other AMPs have been found to be expressed at various sites 7, 8 in addition to the eye. [17] [18] [19] [20] They have been found to increase the antimicrobial property of contact lens cleaning solutions 21 as well as that of corneal storage media. 22 Topical application of AMPs is considered to have considerable therapeutic potential. [23] [24] [25] [26] Therein lies the importance of any new AMP found to be expressed on the ocular surface; the hidden Markov model of the human genome and EST libraries together identify 28 novel ␤-defensin-like genes. However, the AMP DEFB-109 has not been reported in ocular cells. We report for the first time the constitutive expression of DEFB-109 in ocular surface cells obtained by impression cytology. Furthermore, we note a significantly reduced expression of DEFB-109 in impression cytology specimens obtained from the ocular surface in the presence of infection and dry eye. This reduced expression was demonstrated by real-time PCR (quantitative PCR [QPCR]) of the DEFB-109 gene in bacterial, viral, and acanthamoeba ocular infection as well as dry eye.
METHODS
The research was approved by the local ethics committee and the Research and Development Department of the National Health Service Trust. All research was conducted in accordance with the tenets of the Declaration of Helsinki.
Sample Collection
Informed consent was obtained before sample collection. Ocular surface cells were collected from normal eyes of patients coming for evaluation before cataract surgery (n ϭ 3) and from persons with bacterial infection (n ϭ 3), viral infection (n ϭ 3), Acanthamoeba spp. keratitis (n ϭ 3) and dry eye disease (n ϭ 3). Corneal and conjunctival cells were collected by impression cytology. Hydrophilic 13-mm filter paper discs of mixed cellulose esters and pore size 0.45 m (Millipore Corp., Bedford, MA) were used. A hemidisc of filter paper was applied The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
to the ocular surface of interest with a fine nontoothed forceps after the eye was adequately anesthetized with amethocaine (0.5%) or benoxinate (0.4%) drops. Then, the membrane was "peeled" off and stored (Buffer RLT; RNeasy Minikit; Qiagen, Crawley, UK) at Ϫ80°C. To ensure maximum cell recovery, each area was sampled twice.
Testis
PCR-ready human testicular cDNA (0.5 ng/L; Ambion, Huntingdon, UK) was used as a control template for the PCR and QPCR experiments.
Placenta Collection
Fetal membranes were procured from consenting patients undergoing elective caesarean section near term and delivering healthy infants and were processed according to established procedures in our laboratory. 27 Fresh placental samples were collected and RNA extracted. These were used as the control for conventional PCR.
Peripheral Blood Monocytes
Peripheral blood monocytes were isolated by established methods. 28 These were also used as the control for conventional PCR.
Isolation of RNA and cDNA Synthesis
Total RNA was extracted from the corneal and conjunctival impression cytology samples, as well as placenta and PBMCs using a commercial kit (RNeasy Minikit and Qiashredder columns; Qiagen) according to the manufacturer's instructions. Ethanol precipitation of RNA from several pooled samples from each category was performed for those samples in which the RNA concentration was below 44 ng/L, as described by Weichenhan (http://www.science.ngfn.de.index-455.htm).
Reverse transcription of all RNA samples to first-strand cDNA was performed (SuperScript III Reverse Transcriptase; Invitrogen, Paisley, UK) according to the manufacturer's protocol (but replacing RNaseOUT with SuperaseIn; Ambion) and using random hexamer primers (Promega, Southampton, UK).
Polymerase Chain Reaction
Primer sequences for each gene (Table 1) were designed based on sequences retrieved online from the Universal Probe Library (www. 
Gel Electrophoresis Analysis
The products of each PCR were analyzed on ethidium-bromide-stained 1% (wt/vol) agarose gels. All samples were positive for HPRT primers and were analyzed further by QPCR.
Sequencing of Gene of Interest
We sequenced the DNA bands appearing on the gels to confirm the product of interest (Fig. 1 ). An impression cytology sample from a normal individual was run in duplicate, and the two DNA fragments obtained were excised from the agarose gel and pooled, and the manufacturer's (QIAquick Gel Extraction Kit; Qiagen) protocol was used for elution of the DNA. The sample was then air-dried and sent for sequencing (MWG-Biotech) using the reverse primer for DEFB-109.
Real-Time QPCR
Real-time QPCR analysis was performed using DEFB-109 and HPRT primers (MWG Biotech) to allow calculation of the relative abundance of transcripts.
Reactions were prepared with 12.5 L 2ϫ PCR master mix (Brilliant SYBR Green QPCR Master Mix; Stratagene, Amsterdam, The Netherlands), 500 M final concentration of each primer, 0.75 L reference dye (Stratagene), and 5 L of each cDNA (10 ng/L) in a final volume of 25 L. HPRT was used as the reference gene. All reactions were run in a real-time PCR system (Mx3005P; Stratagene). A standard curve was 
Statistical Analysis of Real-Time PCR Data and Relative Quantitation of Gene Expression
The standard curve method 29 was used to calculate relative quantities of gene expression in the different disease groups compared with the control group, using HPRT as the endogenous reference gene. Similar PCR efficiencies for the DEFB-109 and HPRT genes enabled relative quantitation of transcripts by the Pfaffl method, 30 
RESULTS

RT-PCR Analysis of Expression of DEFB-109
RT-PCR showed the expression of DEFB-109 to be constitutive; 1% agarose gel electrophoresis was positive for the gene in all tissues. Placental tissue showed a comparatively low level of gene expression. Impression cytology samples from all disease groups showed clear expression of DEFB-109, as did the control samples (Fig. 4) .
Real-Time Quantitative PCR Analysis of Expression of DEFB-109
We ran three experiments for each of the groups of normal, bacterial, viral, dry eye, and acanthamoeba specimens. Each of the three real-time PCR experiments were run in duplicate with appropriate fivefold serially diluted standards obtained from human reference total RNA (Stratagene). All samples showed expression of the gene of interest in a constitutive manner, and quantitative values of expression were obtained (Table 2) . Significantly reduced expression of DEFB-109 was noted in samples obtained from all four patient groups compared with normal samples. The reduction in quantitative expression of the DEFB-109 gene was in the following order: dry The downregulation of DEFB-109 in all disease groups was significant (P ϭ 0.0399, or P Յ 0.05). Average gene expression levels in each group were also reduced in diseased compared with normal specimens (Fig. 5) .
DISCUSSION
The conjunctiva and cornea are ideally positioned as the first line of defense in the eye, and it is for this reason that the repertoire of ␤-defensins expressed therein warrants thorough study, to understand conclusively the role of these surfaces in innate and acquired immunity. Our discovery of DEFB-109 on the ocular surface expands current knowledge of the repertoire of ocular surface AMPs. The promise of AMPs as therapeutic agents, either alone or as adjuvants to host modulatory factors and standard antimicrobial therapies, further underscores the importance of understanding the full complement of AMPs at this important mucosal surface. The physiological significance of newer AMPs and the nonmicrobicidal functions of all AMPs must be understood before this potential can be realized.
There are approximately 900 AMPs known to exist at various sites. We have already shown expression of a number of AMPs on the ocular surface.
20 ␣-Defensin-1 to -3 were demonstrated in neutrophils of inflamed conjunctiva and HBD1 and -2 in ocular surface epithelium. 17, 18 In contrast to most epithelial sites where HBD1 is constitutively expressed and HBD2 is inducible, at the ocular surface both these defensins are constitutively expressed. 17, 18, 20 Other AMPs of note demonstrated at the ocular surface include HBD3, liver-expressed AMPs 1 and 2 (LEAP1, -2) and cathelicidin (LL37). 20 In our earlier study, we noted that the highest normalized expression levels by means of real-time PCR were for HBD1, -2, and -3 and LEAP2. 20 Beta defensins have been demonstrated to have good activity against most bacteria and excellent activity against highly resistant bacteria, such as Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus, with a minimum inhibitory concentration (MIC) of 1 to 4 g/mL against the latter group. 30 It is likely that more AMPs and their roles remain to be discovered and elucidated. Primers designed on the basis of the hidden Markov model and expressed sequence tag (EST) libraries have been used to identify numerous AMPs in the human testis, namely HBD3, -4, LEAP1, LEAP2, and LL37, and 8 of 13 putative ␤-defensins. However, these primers did not detect in the ocular epithelium, 20 supporting the notion that not all AMPs are expressed at all sites.
We collected cells from the conjunctival and corneal surfaces of normal persons presenting for preoperative evaluation before cataract extraction and also from patients with bacterial, viral, acanthamoeba infection, and dry eye, by means of impression cytology. Impression cytology is an established noninvasive technique of conjunctival biopsy 31,32 which we have modified to improve efficacy. 33 We are able to harvest the top two or three layers of ocular surface cells by this method. Each area was sampled twice to ensure an adequate sheet of cells. We used human testis cells, human placenta, and PBMC as control samples. Conventional PCR using cDNA reversetranscribed from the RNA of the above samples showed constitutive expression of DEFB-109 in all the tissues taken. The level of expression in placenta was less than in the other samples (Fig. 4) . Quantitative real-time PCR 34 was subsequently run for these samples. Premratanachai et al. 35 have investigated the expression and regulation of novel ␤-defensins DEFB-104 to -114 in gingival keratinocytes. They reported the constitutive expression of DEFB-109 and its downregulation after stimulation with Candida albicans. However, their work was on cultured gingival keratinocytes rather than on cell samples, as in our study. Though others 36 have detected downregulation of LL37 in lower gut infection, our previous work failed to detect any such trend in ocular infections. 20 Hence, the profile and behavior of AMPs of the ocular surface are distinct and unique to this site. The expression of DEFB-109 was seen to be constitutive. This is in keeping with its close relationship with HBD1 in phylogenetic terms, as deduced by Kao et al. 37 based on their genome-wide search of the hidden Markov model profile against the ORFeome peptide database (available in the public domain at www.orfeomecollaboration.org) for this and other novel DEFB genes. Of interest, DEFB-109 showed reduced expression in each of the infected patient categories. The downregulation of the gene seen by Premratanachai et al. 35 in their patients with Candida infection was proposed to be an escape strategy encouraging commensalism of the organism. 26 As alluded to earlier, this phenomenon has also been seen with HBD1 and LL-37 in human shigellosis. In this instance, it was suggested to be a bacterial virulence factor. 36 Also, HBD2 has been found to be decreased in human burn wounds, which may be related to the elevation of one or more of the proinflammatory cytokines IL-1, IL-6, INF-␥, and TNF-␣ in these patients. 38 It appears that infection and inflammation are associated with reduced expression of DEFB-109. Whether the reduced expression is a cause or effect of the infection is unclear. It remains to be seen what relationship, if any, exists between this defensin and the cytokines, which are known to be a part of the intracellular signaling cascade. At the moment there are many possibilities. Further investigation into these interactions will be necessary as more novel peptides are discovered by the aforementioned and other computational strategies. This is the first report of expression of the novel AMP DEFB-109 on the ocular surface. It may play a role in wound healing, similar to some of the other AMPs referred to herein, and is unlikely to have a major antimicrobial effect, as it is reduced in microbial infection. Further investigation into protein expression and signaling pathways will shed light on its definite role. Nonetheless, the unequivocal downregulation of this gene in inflammation (dry eye) and even more so in infection may have important implications in understanding the link between these peptides and myriad other aspects of inflammation. On the other hand, it may represent an intriguing mechanism of immunoevasion by microbes, as Bishop and Finlay 39 argue that AMPs can trigger pathogen virulence. If that is the case, strategies to reverse such evasion must be discovered.
